Frazier Financial Advisors, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2002745
COLUMBUS, OH
Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$11,797
+$2,576 QoQ
Shares Held
70
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#680
of 768 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Frazier Financial Advisors, LLC holds $20,635 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (57.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
70 | $11,797 | |
| 2 | ZTS |
Zoetis Inc.
|
123 | $8,838 |
All Filings in NBIX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,797 | 70 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,221 | 70 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $9,928 | 70 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,826 | 70 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $8,798 | 70 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $7,742 | 70 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $9,555 | 70 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,065 | 70 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $9,636 | 70 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,654 | 70 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $9,223 | 70 | Shares | Sole | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||